103 related articles for article (PubMed ID: 183576)
1. Cholestyramine: an effective, twice-daily dosage regimen.
Blum CB; Havlik RJ; Morganroth J
Ann Intern Med; 1976 Sep; 85(3):287-9. PubMed ID: 183576
[TBL] [Abstract][Full Text] [Related]
2. Dose-effect relation of cholestryamine in children and young adults with familial hypercholesterolaemia.
Farah JR; Kwiterovich PO; Neill CA
Lancet; 1977 Jan; 1(8002):59-63. PubMed ID: 63709
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
4. Cholestyramine in type IIa hyperlipoproteinemia. Is low-dose treatment feasible?
Angelin B; Einarsson K
Atherosclerosis; 1981; 38(1-2):33-8. PubMed ID: 7470203
[TBL] [Abstract][Full Text] [Related]
5. A study of the dose-effect relationship of cholestyramine in children with familial hypercholesterolemia.
Farah JR; Kwiterovich PO; Neill CA
Adv Exp Med Biol; 1977; 82():212-5. PubMed ID: 200092
[No Abstract] [Full Text] [Related]
6. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.
Glueck CJ; Tsang RC; Fallat RW; Mellies M
Pediatrics; 1977 Mar; 59(3):433-41. PubMed ID: 840563
[TBL] [Abstract][Full Text] [Related]
7. Cholestyramine plus pectin in treatment of patients with familial hypercholesterolemia.
Schwandt P; Richter WO; Weisweiler P; Neureuther G
Atherosclerosis; 1982 Sep; 44(3):379-83. PubMed ID: 7150399
[TBL] [Abstract][Full Text] [Related]
8. Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemia.
Series JJ; Caslake MJ; Kilday C; Cruickshank A; Demant T; Lorimer AR; Packard CJ; Shepherd J
Metabolism; 1989 Feb; 38(2):153-8. PubMed ID: 2643751
[TBL] [Abstract][Full Text] [Related]
9. A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
Mann JI; Harding PA; Turner RC; Wilkinson RH
Br J Clin Pharmacol; 1977 Jun; 4(3):305-8. PubMed ID: 197982
[TBL] [Abstract][Full Text] [Related]
10. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
Therapie; 1978; 33(5):615-22. PubMed ID: 217121
[No Abstract] [Full Text] [Related]
11. Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
Glueck CJ; Tsang RC; Fallat RW; Scheel D
Pediatrics; 1974 Jul; 54(1):51-5. PubMed ID: 4365953
[No Abstract] [Full Text] [Related]
12. Cholestyramine for elevated serum cholesterol.
Med Lett Drugs Ther; 1974 Apr; 16(8):33-4. PubMed ID: 4362570
[No Abstract] [Full Text] [Related]
13. Cholestyramine in hypercholesterolaemia.
West R; Lloyd JK
Lancet; 1977 Feb; 1(8009):488-9. PubMed ID: 65596
[No Abstract] [Full Text] [Related]
14. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
[TBL] [Abstract][Full Text] [Related]
15. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III.
JAMA; 1988 Jul; 260(3):359-66. PubMed ID: 2898027
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hypercholesterolemia with Secholex. A long-term clinical trial and comparison with cholestyramine.
Nikkila EA; Miettinen TA; Lanner A
Atherosclerosis; 1976 Sep; 24(3):407-19. PubMed ID: 971343
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
[TBL] [Abstract][Full Text] [Related]
18. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
[TBL] [Abstract][Full Text] [Related]
19. Pseudohomozygous type II hyperlipoproteinemia.
Morganroth J; Levy RI; McMahon AE; Gotto AM
J Pediatr; 1974 Nov; 85(5):639-43. PubMed ID: 4370845
[No Abstract] [Full Text] [Related]
20. [The efficacy of cholestyramine as a hypocholesterolemic agent and its tolerance in a Mexican population].
Lerman Garber I; Cardoso Saldaña G; Zamora González J; Ahumada Ayala M; García Rubí E; Posadas Romero C
Arch Inst Cardiol Mex; 1991; 61(1):47-51. PubMed ID: 2048910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]